Is Cytokinetics, Incorporated (CYTK) a Buy, Sell, or Hold?
Cytokinetics, Incorporated
NASDAQ:CYTK
$82.3915 USD
$0.46 (0.56%)
- Volume
- 689.39K
- Average Volume
- 2.62M
- Market Capitalization
- $10.25B
- P/E Ratio
- -12.06
- Dividend Yield
- 0.00%
- Price Target
- $108.00
- Year High
- $88.31
- Year Low
- $32.89
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.21
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-23.7% DOWNSIDE
$108.00 Price Target
UPSIDE/DOWNSIDE HIGH
-41.1% DOWNSIDE
$140.00 Price Target High
UPSIDE/DOWNSIDE LOW
-1.9% DOWNSIDE
$84.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| RBC Capital | Leonid Timashev | $117 | $85.57 | 2026-07-07 07:30 AM | 36.7% |
| UBS | Ashwani Verma | $115 | $82.19 | 2026-06-29 06:19 AM | 39.9% |
| RBC Capital | Leonid Timashev | $119 | $75.21 | 2026-06-17 07:34 AM | 58.2% |
| Truist Financial | Srikripa Devarakonda | $106 | $76.59 | 2026-05-05 10:26 AM | 38.4% |